(Q35879043)

10 August 2017

1 reference

title

Pulmonary alveolar proteinosis. What is the role of GM-CSF in disease pathogenesis and treatment? (English)

1 reference

10 August 2017

John F Seymour

1

1 reference

10 August 2017

Jeffrey J Presneill

series ordinal

2

1 reference

10 August 2017

publication date

1 January 2004

1 reference

Treatments in Respiratory Medicine

10 August 2017

published in

1 reference

10 August 2017

volume

3

1 reference

10 August 2017

issue

4

1 reference

10 August 2017

page(s)

229-234

1 reference

The lavage fluid from a patient with alveolar proteinosis inhibits the in vitro chemiluminescence response and arachidonic acid metabolism of normal guinea pig alveolar macrophages

10 August 2017

cites work

1 reference

https://api.crossref.org/works/10.2165%2F00151829-200403040-00003

Autoantibodies against granulocyte macrophage colony-stimulating factor are diagnostic for pulmonary alveolar proteinosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00151829-200403040-00003

Defective Lung Macrophages in Pulmonary Alveolar Proteinosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00151829-200403040-00003

Endocytic internalization of adenovirus, nonspecific phagocytosis, and cytoskeletal organization are coordinately regulated in alveolar macrophages by GM-CSF and PU.1.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00151829-200403040-00003

Exogenous granulocyte-macrophage colony-stimulating factor administration for pulmonary alveolar proteinosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00151829-200403040-00003

10.2165/00151829-200403040-00003

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

10 August 2017

1008691659

0 references

1 reference